{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:20:28Z","timestamp":1789129228379,"version":"build-2803163510"},"reference-count":130,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"DOI":"10.1309\/ajcpan7bh5dnywzb","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T17:32:36Z","timestamp":1439573556000},"page":"393-410","source":"Crossref","is-referenced-by-count":57,"title":["B-Acute Lymphoblastic Leukemia\/Lymphoblastic Lymphoma"],"prefix":"10.1093","volume":"144","author":[{"given":"Sanam","family":"Loghavi","sequence":"first","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery L.","family":"Kutok","sequence":"additional","affiliation":[{"name":"Infinity Pharmaceuticals, Cambridge, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,1]]},"reference":[{"key":"key\n\t\t\t\t20180602035151_b1-1440393","first-page":"168","article-title":"B lymphoblastic leukaemia\/lymphoma, not otherwise specified","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Borowitz","year":"2008","edition":"4th"},{"key":"key\n\t\t\t\t20180602035151_b2-1440393","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9343(94)90049-3","article-title":"Philadelphia-chromosome\u2013positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients","volume":"97","author":"Preti","year":"1994","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180602035151_b3-1440393","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","article-title":"Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia","volume":"91","author":"Faderl","year":"1998","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b4-1440393","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"issue":"suppl 2","key":"key\n\t\t\t\t20180602035151_b5-1440393","first-page":"S36","article-title":"Imatinib for relapsed BCR\/ABL positive leukemias","volume":"81","author":"Ottmann","year":"2002","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t20180602035151_b6-1440393","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.leu.2402770","article-title":"Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)","volume":"16","author":"Wassmann","year":"2002","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b7-1440393","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180602035151_b8-1440393","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2009-12-261586","article-title":"First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome\u2013positive (Ph+) acute lymphoblastic leukemia","volume":"116","author":"Ravandi","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b9-1440393","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2006-11-052373","article-title":"Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"110","author":"Pfeifer","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b10-1440393","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-11-1227","article-title":"CDKN2A\/B alterations impair prognosis in adult BCR-ABL1\u2013positive acute lymphoblastic leukemia patients","volume":"17","author":"Iacobucci","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180602035151_b11-1440393","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1\u2013induced B-lymphoblastic leukemia but not chronic myeloid leukemia","volume":"36","author":"Hu","year":"2004","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180602035151_b12-1440393","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10428190701713689","article-title":"Src-family kinases in the development and therapy of Philadelphia chromosome\u2013positive chronic myeloid leukemia and acute lymphoblastic leukemia","volume":"49","author":"Li","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602035151_b13-1440393","first-page":"1724","article-title":"BCR\/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats","volume":"10","author":"Frank","year":"1996","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b14-1440393","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","article-title":"P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members","volume":"271","author":"Ilaria","year":"1996","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180602035151_b15-1440393","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1182\/blood-2009-02-204693","article-title":"Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance","volume":"114","author":"Verma","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b16-1440393","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180602035151_b17-1440393","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2007-02-073528","article-title":"Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study","volume":"110","author":"Ottmann","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b18-1440393","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ajh.21615","article-title":"Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: results from a phase 3 study","volume":"85","author":"Lilly","year":"2010","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20180602035151_b19-1440393","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/sj.leu.2400836","article-title":"Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR\/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG\/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group\/Medical Research Council","volume":"11","author":"Paietta","year":"1997","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b20-1440393","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.leu.2402060","article-title":"Adult precursor B-ALL with BCR\/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression","volume":"15","author":"Tabernero","year":"2001","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b21-1440393","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1309\/AJCP8G5RMTWUEMUU","article-title":"Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia","volume":"132","author":"Seegmiller","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b22-1440393","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1002\/cncr.25978","article-title":"Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors","volume":"117","author":"Jaso","year":"2011","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180602035151_b23-1440393","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.leu.2400989","article-title":"Down\u2019s syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Munster Group","volume":"12","author":"Dordelmann","year":"1998","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b24-1440393","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/adc.85.4.321","article-title":"Down\u2019s syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment","volume":"85","author":"Chessells","year":"2001","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t20180602035151_b25-1440393","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-10-3446","article-title":"Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children\u2019s Cancer Group study","volume":"106","author":"Whitlock","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b26-1440393","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1182\/blood-2007-09-114231","article-title":"Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study","volume":"111","author":"Forestier","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b27-1440393","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.febslet.2010.09.042","article-title":"Ikaros in immune receptor signaling, lymphocyte differentiation, and function","volume":"584","author":"Merkenschlager","year":"2010","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20180602035151_b28-1440393","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3324\/haematol.13260","article-title":"Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method","volume":"93","author":"Iacobucci","year":"2008","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180602035151_b29-1440393","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20090004","article-title":"Pre\u2013B cell receptor-mediated cell cycle arrest in Philadelphia chromosome\u2013positive acute lymphoblastic leukemia requires IKAROS function","volume":"206","author":"Trageser","year":"2009","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180602035151_b30-1440393","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602035151_b31-1440393","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","article-title":"IKZF1 (Ikaros) deletions in BCR-ABL1\u2013positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report","volume":"27","author":"Martinelli","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180602035151_b32-1440393","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/leu.2010.87","article-title":"IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL","volume":"24","author":"Kuiper","year":"2010","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b33-1440393","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/leu.2010.275","article-title":"Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia","volume":"25","author":"Waanders","year":"2011","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b34-1440393","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1349-7006.2011.02031.x","article-title":"IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan","volume":"102","author":"Yang","year":"2011","journal-title":"Cancer Sci"},{"key":"key\n\t\t\t\t20180602035151_b35-1440393","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1\u2013like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b36-1440393","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood-2013-06-509794","article-title":"IKZF1 status as a prognostic feature in BCR-ABL1\u2013positive childhood ALL","volume":"123","author":"van der Veer","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b37-1440393","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/leu.2013.206","article-title":"Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011","volume":"28","author":"Olsson","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b38-1440393","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180602035151_b39-1440393","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/ehm.09.16","article-title":"New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia","volume":"2","author":"Martinelli","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"key\n\t\t\t\t20180602035151_b40-1440393","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180602035151_b41-1440393","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/ejh.12155","article-title":"High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia","volume":"91","author":"Tokunaga","year":"2013","journal-title":"Eur J Haematol"},{"key":"key\n\t\t\t\t20180602035151_b42-1440393","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.20042101","article-title":"Mimicry of a constitutively active pre\u2013B cell receptor in acute lymphoblastic leukemia cells","volume":"201","author":"Feldhahn","year":"2005","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180602035151_b43-1440393","doi-asserted-by":"crossref","first-page":"e40934","DOI":"10.1371\/journal.pone.0040934","article-title":"IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia","volume":"7","author":"Iacobucci","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180602035151_b44-1440393","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180602035151_b45-1440393","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcmd.2010.02.011","article-title":"Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: a study of 7 patients and review of the literature","volume":"44","author":"De Braekeleer","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20180602035151_b46-1440393","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.molonc.2011.08.003","article-title":"Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory","volume":"5","author":"De Braekeleer","year":"2011","journal-title":"Mol Oncol"},{"key":"key\n\t\t\t\t20180602035151_b47-1440393","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b48-1440393","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.1998.16.12.3768","article-title":"Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia","volume":"16","author":"Pui","year":"1998","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180602035151_b49-1440393","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood-2005-05-1866","article-title":"CD10- pre\u2013B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL)","volume":"106","author":"Gleissner","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b50-1440393","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood.V77.3.440.440","article-title":"Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases","volume":"77","author":"Pui","year":"1991","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b51-1440393","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2005-05-1932","article-title":"The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivo","volume":"106","author":"Stover","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b52-1440393","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1182\/blood-2006-01-0285","article-title":"The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib)","volume":"107","author":"von Bubnoff","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b53-1440393","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajh.23664","article-title":"World Health Organization\u2013defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management","volume":"89","author":"Gotlib","year":"2014","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20180602035151_b54-1440393","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood.V73.8.2081.2081","article-title":"The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene","volume":"73","author":"Grimaldi","year":"1989","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b55-1440393","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.04948.x","article-title":"Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia","volume":"125","author":"Harrison","year":"2004","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602035151_b56-1440393","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM198805263182106","article-title":"Activation of the c-myc oncogene in a precursor\u2013B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma","volume":"318","author":"De Jong","year":"1988","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602035151_b57-1440393","first-page":"431","article-title":"Pre\u2013B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma","volume":"2","author":"Gauwerky","year":"1988","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180602035151_b58-1440393","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18) (q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t20180602035151_b59-1440393","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF01698379","article-title":"Translocation (14; 18) and (8; 22) in three patients with acute leukemia\/lymphoma following centrocytic\/centroblastic non-Hodgkin\u2019s lymphoma","volume":"63","author":"Fiedler","year":"1991","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t20180602035151_b60-1440393","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/Y2YD-UNA2-C95R-AVM3","article-title":"Precursor B-lymphoblastic transformation of grade I follicle center lymphoma","volume":"113","author":"Kroft","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b61-1440393","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5858\/2002-126-0997-TOFLTA","article-title":"Transformation of follicular lymphoma to acute lymphoblastic leukemia","volume":"126","author":"Sun","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t20180602035151_b62-1440393","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1080\/10428190600612909","article-title":"Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: implications for lymphomagenesis","volume":"47","author":"Kobrin","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602035151_b63-1440393","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1309\/NKK3FEX2BE5L7EKB","article-title":"Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event","volume":"129","author":"Young","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b64-1440393","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/dc.22871","article-title":"Follicular lymphoma transformed to \u201cdouble-hit\u201d B lymphoblastic lymphoma presenting in the peritoneal fluid","volume":"41","author":"Kaplan","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"key\n\t\t\t\t20180602035151_b65-1440393","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180602035151_b66-1440393","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1080\/10428190903093815","article-title":"Predicting transformation in follicular lymphoma","volume":"50","author":"de Jong","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602035151_b67-1440393","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1182\/blood.V62.5.1142.1142","article-title":"Common ALL with pre\u2013B-cell features showing (8;14) and (14;18) chromosome translocations","volume":"62","author":"Mufti","year":"1983","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b68-1440393","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.81.22.7166","article-title":"A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia","volume":"81","author":"Pegoraro","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180602035151_b69-1440393","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.2870020211","article-title":"Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18) (q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11)","volume":"2","author":"Thangavelu","year":"1990","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t20180602035151_b70-1440393","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-9343(90)90175-D","article-title":"The importance of cytogenetic studies in adult acute lymphocytic leukemia","volume":"89","author":"Walters","year":"1990","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180602035151_b71-1440393","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-4608(91)90188-Z","article-title":"Lymphoblastic lymphoma with primary splenic involvement and the classic 14;18 translocation","volume":"57","author":"Carli","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"key\n\t\t\t\t20180602035151_b72-1440393","first-page":"473","article-title":"De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosis","volume":"5","author":"Kramer","year":"1991","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b73-1440393","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V82.1.231.bloodjournal821231","article-title":"C-MYC translocations in de novo B-cell lineage acute leukemias with t(14;18)(cell lines Karpas 231 and 353)","volume":"82","author":"Nacheva","year":"1993","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b74-1440393","first-page":"1159","article-title":"Coexpression of cell-surface immunoglobulin (sIg), terminal deoxynucleotidyl transferase (TdT) and recombination activating gene 1 (RAG-1): two cases and derived cell lines","volume":"10","author":"Nakamura","year":"1996","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b75-1440393","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1309\/P7QG-0993-WRAJ-VTNA","article-title":"Acute lymphoblastic leukemia in elderly patients the Philadelphia chromosome may not be a significant adverse prognostic factor","volume":"117","author":"Onciu","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b76-1440393","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0609.2004.00338.x","article-title":"Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18) (q32;q21)","volume":"74","author":"Hardianti","year":"2005","journal-title":"Eur J Haematol"},{"key":"key\n\t\t\t\t20180602035151_b77-1440393","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602035151_b78-1440393","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3109\/10428194.2011.589548","article-title":"De novo B lymphoblastic leukemia\/lymphoma in an adult with t(14;18) (q32;q21) and c-MYC gene rearrangement involving 10p13","volume":"52","author":"Subramaniyam","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602035151_b79-1440393","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cancergen.2013.04.004","article-title":"Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature","volume":"206","author":"Chapiro","year":"2013","journal-title":"Cancer Genet"},{"key":"key\n\t\t\t\t20180602035151_b80-1440393","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3343\/alm.2012.32.4.289","article-title":"MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia","volume":"32","author":"Seo","year":"2012","journal-title":"Ann Lab Med"},{"key":"key\n\t\t\t\t20180602035151_b81-1440393","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b82-1440393","first-page":"46","article-title":"Morphology and incidence of the \u201cposttherapeutic lymphoid cell\u201d in the bone marrow of children with acute lymphoblastic leukemia","volume":"124","author":"Schuurmans Stekhoven","year":"1986","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180602035151_b83-1440393","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.V72.1.299.299","article-title":"Asynchronous antigen expression in B lineage acute lymphoblastic leukemia","volume":"72","author":"Hurwitz","year":"1988","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b84-1440393","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.leu.2401364","article-title":"A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection","volume":"13","author":"Weir","year":"1999","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b85-1440393","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0889-8588(05)70185-4","article-title":"Immunophenotypes in adult acute lymphocytic leukemia: role of flow cytometry in diagnosis and monitoring of disease","volume":"14","author":"Huh","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"key\n\t\t\t\t20180602035151_b86-1440393","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1309\/LXU4-Q7Q9-3YAB-4QE0","article-title":"Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features","volume":"114","author":"Rimsza","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b87-1440393","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry","volume":"98","author":"McKenna","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b88-1440393","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0889-8588(02)00004-7","article-title":"Immunophenotypic analysis of acute lymphocytic leukemia","volume":"16","author":"Riley","year":"2002","journal-title":"Hematol Oncol Clin North Am"},{"key":"key\n\t\t\t\t20180602035151_b89-1440393","first-page":"416","article-title":"Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype","volume":"50","author":"Mlcakova","year":"2003","journal-title":"Neoplasma"},{"key":"key\n\t\t\t\t20180602035151_b90-1440393","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/1042819031000151950","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry","volume":"45","author":"McKenna","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602035151_b91-1440393","first-page":"502","article-title":"The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia","volume":"52","author":"Babusikova","year":"2005","journal-title":"Neoplasma"},{"key":"key\n\t\t\t\t20180602035151_b92-1440393","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/7R6MU7R9YWJBY5V4","article-title":"Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia\/lymphoma: a single institution experience","volume":"127","author":"Chen","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b93-1440393","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1080\/10428190701817274","article-title":"Hematogones in acute leukemia during and after therapy","volume":"49","author":"Babusikova","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602035151_b94-1440393","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1309\/AJCPO4DS0GTLSOEI","article-title":"Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors (\u201chematogones\u201d) and B lymphoblastic leukemia blasts","volume":"132","author":"Hassanein","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b95-1440393","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1309\/AJCP02RPVOKTNWEC","article-title":"Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry","volume":"132","author":"Muzzafar","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b96-1440393","first-page":"150","article-title":"Acute leukemias of ambiguous lineage","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Borowitz","year":"2008","edition":"4th"},{"key":"key\n\t\t\t\t20180602035151_b97-1440393","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602035151_b98-1440393","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b99-1440393","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjh.12277","article-title":"Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia","volume":"161","author":"Guy","year":"2013","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602035151_b100-1440393","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/cytob.21155","article-title":"Mixed phenotype acute leukemia","volume":"86","author":"Borowitz","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"key\n\t\t\t\t20180602035151_b101-1440393","first-page":"741","article-title":"Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome\u2013positive acute lymphoblastic leukemia","volume":"10","author":"Pane","year":"1996","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b102-1440393","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/1097-0142(19940301)73:5<1526::AID-CNCR2820730534>3.0.CO;2-E","article-title":"Lineage switch in Philadelphia chromosome\u2013positive acute lymphoblastic leukemia","volume":"73","author":"Reardon","year":"1994","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180602035151_b103-1440393","first-page":"192S","article-title":"Mixed-lineage leukemias and phenotypic shifts occurring in relapsed cases of acute T lymphoblastic lymphomas","volume":"2","author":"Delia","year":"1988","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b104-1440393","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cyto.b.20071","article-title":"Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children\u2019s oncology group","volume":"68","author":"Borowitz","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"key":"key\n\t\t\t\t20180602035151_b105-1440393","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2141.1999.01636.x","article-title":"Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto","volume":"106","author":"Pagano","year":"1999","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602035151_b106-1440393","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.leu.2402918","article-title":"High frequency of pro\u2013B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities","volume":"17","author":"Ishizawa","year":"2003","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b107-1440393","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdn182","article-title":"Biologic features and treatment outcome of secondary acute lymphoblastic leukemia\u2014a review of 101 cases","volume":"19","author":"Shivakumar","year":"2008","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180602035151_b108-1440393","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1309\/AJCPYWC6AQC7BAVJ","article-title":"Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review","volume":"133","author":"Chen","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602035151_b109-1440393","first-page":"1800","article-title":"Therapy-related B lymphoblastic leukemia with t(4;11)(q21;q23)\/AF4-MLL in a patient with mantle cell lymphoma after recent aggressive chemotherapy\u2014a unique case report","volume":"7","author":"Holdener","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"key\n\t\t\t\t20180602035151_b110-1440393","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3324\/haematol.2011.057752","article-title":"Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related","volume":"97","author":"Tang","year":"2012","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180602035151_b111-1440393","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2141.2001.03000.x","article-title":"Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992","volume":"114","author":"Andersen","year":"2001","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602035151_b112-1440393","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/gcc.10046","article-title":"11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop","volume":"33","author":"Bloomfield","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t20180602035151_b113-1440393","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/sj.leu.2402713","article-title":"Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976\u20131993 and on 5098 unselected cases reported in the literature 1974\u20132001","volume":"16","author":"Mauritzson","year":"2002","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602035151_b114-1440393","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/1042819031000079078","article-title":"Atypical hemophagocytic lymphohistiocytosis following bacterial tonsillitis in acute lymphoblastic leukemia","volume":"44","author":"Kakihara","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602035151_b115-1440393","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ajh.20123","article-title":"Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia","volume":"76","author":"Goldschmidt","year":"2004","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20180602035151_b116-1440393","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/10428190500160017","article-title":"Histiocytosis following T-acute lymphoblastic leukemia: a BFM study","volume":"46","author":"Trebo","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602035151_b117-1440393","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/pbc.20771","article-title":"Epstein-Barr virus associated hemophagocytic lymphohystiocytosis during maintenance treatment of acute lymphoblastic leukemia","volume":"46","author":"Kuzmanovic","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"key\n\t\t\t\t20180602035151_b118-1440393","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1532\/IJH97.06101","article-title":"Late-onset fatal Epstein-Barr virus\u2013associated hemophagocytic syndrome following cord blood cell transplantation for adult acute lymphoblastic leukemia","volume":"84","author":"Kawabata","year":"2006","journal-title":"Int J Hematol"},{"key":"key\n\t\t\t\t20180602035151_b119-1440393","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/pbc.20950","article-title":"Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis","volume":"50","author":"O\u2019Brien","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"key\n\t\t\t\t20180602035151_b120-1440393","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/MPH.0b013e3181864ab9","article-title":"Hemophagocytic lymphohistiocytosis onset during induction therapy for precursor B-cell acute lymphoblastic leukemia","volume":"30","author":"Breakey","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t20180602035151_b121-1440393","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s12185-008-0208-y","article-title":"Hemophagocytic lymphohistiocytosis during maintenance treatment of precursor B-cell acute lymphoblastic leukemia","volume":"88","author":"Furutani","year":"2008","journal-title":"Int J Hematol"},{"key":"key\n\t\t\t\t20180602035151_b122-1440393","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/pbc.22688","article-title":"Hemophagocytic lymphohistiocytosis associated with precursor B acute lymphoblastic leukemia","volume":"56","author":"Kelly","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"key\n\t\t\t\t20180602035151_b123-1440393","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12185-014-1591-1","article-title":"Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by the Kyushu-Yamaguchi Children\u2019s Cancer Study Group","volume":"100","author":"Moritake","year":"2014","journal-title":"Int J Hematol"},{"key":"key\n\t\t\t\t20180602035151_b124-1440393","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b125-1440393","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrclinonc.2013.46","article-title":"Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors","volume":"10","author":"Kochenderfer","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"key\n\t\t\t\t20180602035151_b126-1440393","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b127-1440393","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20180602035151_b128-1440393","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602035151_b129-1440393","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602035151_b130-1440393","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/144\/3\/393\/25000436\/ajcpath144-0393.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T15:06:02Z","timestamp":1718031962000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/144\/3\/393\/1760791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":130,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,9,1]]},"published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpan7bh5dnywzb","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,9,1]]},"published":{"date-parts":[[2015,9,1]]}}}